// App-Quantinova.ai

TCT-489 : Three-Year Outcomes of Patients Treated With the Firehawk Stent Versus XIENCE Stent on the Basis of Diabetes Status: Subgroup Analysis of the TARGET All Comers Trial

Researchers

Presenter

  • Yasin Hussain

Principal Investigators

  • Bo Xu

  • Henning Kelbæk

  • Paul Knaapen

  • Ming Zheng

  • Ton Slagboom

  • Thomas Johnson

  • Pieter Smits

  • Karin Arkenbout

  • Lene Holmvang

  • Luc Janssens

  • Andrzej Ochala

  • Salvatore Brugaletta

  • Thomas Schmitz

  • Richard Anthony Anderson

  • Harald Rittger

  • Sergio Berti

  • Emanuele Barbato

  • Gabor Toth

  • Luc Maillard

  • Christian Valina

  • Paweł Buszman

  • Holger Thiele

  • Volker Schachinger

  • Andreas Baumbach

  • Alexandra Lansky

Medical Centers

  • Roskilde Hospital, Roskilde, Denmark

  • Hospital Clinic, University of Barcelona, Barcelona, Spain

  • Contilia Heart Center, Essen, Germany

  • Klinikum Fulda, Fulda, Germany

  • Shanghai Microport, Shanghai, China

  • Center of Cardiovascular Research and Development, American Heart of Poland, Katowice, Poland

  • University Hospital of Wales, Caerdydd, United Kingdom

  • Fu Wai Hospital, National Center for Cardiovascular Diseases, China, Beijing, China

  • University Heart Centre Graz, Graz, Austria

  • Imelda Hospital Bonheiden, Bonheiden, Belgium

  • OLVG, Amsterdam, the Netherlands

  • VU University Medical Center, Amsterdam, Netherlands

  • Rigshospitalet, Copenhagen, Denmark

  • Cheltenham General Hospital, Auckland, New Zealand

  • Yale School of Medicine, New Haven, Connecticut, USA

  • Cardiovascular Center Aalst, OLV-Clinic, Aalst, Belgium

  • Heart Center Leipzig at University of Leipzig, Leipzig, Germany

  • University Heartcenter Bad Krozingen, Bad Krozingen, Germany

  • Fondazione C.N.R. Toscana G. Monasterio, Massa, Massa and Carrara, Italy

  • Department of Cardiology, Tergooi Hospital, Blaricum, Netherlands

  • University Hospital, Katowice, Poland

  • Lambe Institute for Translational Medicine and CURAM, Galway, Ireland

  • Klinikum Fuerth, Fuerth, Germany

  • GCS ES Axium Rambot, Aix-en-Provence, France

  • Maasstad Ziekenhuis, Rotterdam, Netherlands

  • Barts Heart Centre, London, United Kingdom

Locations

  • Denmark

  • New Zealand

  • Spain

  • United States

  • Germany

  • Belgium

  • China

  • Poland

  • Italy

  • United Kingdom

  • Netherlands

  • Austria

  • Ireland

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Myocardial infarction

  • Venous thrombosis

  • Diabetes

  • Coronary Artery Disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved